- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Anthera Pharmaceuticals Inc
+ Add to WatchlistANTH:US
0.5999 USD 0.0070 1.15%As of 20:10:00 ET on 05/24/2013.
Company Profile for Anthera Pharmaceuticals Inc (ANTH)
Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.
Contact Information
Anthera Pharmaceuticals Inc
25801 Industrial Boulevard
Suite B
Hayward, CA 94545
United States
Phone: 1-510-856-5600
Key Executives for Anthera Pharmaceuticals Inc (ANTH)
| Christopher S HenneyChairman | Paul F TruexPresident/CEO/Founder |
| Christopher P LoweCFO/Chief Business Officer | Debra OdinkSenior VP/CTO |
| Colin HislopSenior VP/Chief Medical Ofcr | Paula AdamsVP:Regulatory Affairs |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page